The University of Queensland is set to take a second-generation molecular clamp vaccine to a proof-of-concept human trial.
The Coalition for Epidemic Preparedness Innovation (CEPI) has announced in Brisbane today that it will provide up to AU$8.5 million to support further development of the re-engineered technology for use in the global response to future disease outbreaks.
